Cas:90915-78-9 N-[4-(cyanomethylsulfonyl)phenyl]acetamide manufacturer & supplier

We serve Chemical Name:N-[4-(cyanomethylsulfonyl)phenyl]acetamide CAS:90915-78-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[4-(cyanomethylsulfonyl)phenyl]acetamide

Chemical Name:N-[4-(cyanomethylsulfonyl)phenyl]acetamide
CAS.NO:90915-78-9
Synonyms:acetamidophenylsulfonylacetonitrile;(N-acetyl-sulfanilyl)-acetonitrile;Essigsaeure-(4-cyanmethylsulfon-anilid);Cyan-methyl-(4-acetamino-phenyl)-sulfon;(4-Acetamino-phenylsulfon)-acetonitril;4-(acetamidophenylsulfonyl)acetonitrile
Molecular Formula:C10H10N2O3S
Molecular Weight:238.26300
HS Code:2926909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:562.3ºC at 760 mmHg
Density:1.367g/cm3
Index of Refraction:1.577
PSA:95.41000
Exact Mass:238.04100
LogP:2.09608

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like acetamidophenylsulfonylacetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(acetamidophenylsulfonyl)acetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyan-methyl-(4-acetamino-phenyl)-sulfon Use and application,4-(acetamidophenylsulfonyl)acetonitrile technical grade,usp/ep/jp grade.


Related News: CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 2-Decyldimethylammonio-aethan-sulfonsaeure-(1)-betain, Decyldimethyltaurinbetain manufacturers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. Decarboxylase, malonate (Acinetobacter calcoaceticus gene mdcCsubunit g) suppliers The client needed full development and product readiness with an extremely short supply of the API. In addition, the scale-up batch was small because of the low volume of product demands of their orphan drug. 9,10-Anthracenedione,1,5-bis[[4-(1,1-dimethylethyl)phenyl]thio]-4,8-bis[[4′-(trans-4-pentylcyclohexyl)[1,1′-biphenyl]-4-yl]thio]- vendor & factory.